Related references
Note: Only part of the references are listed.Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
Philipp Nuhn et al.
EUROPEAN UROLOGY (2019)
Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
Valentina Rossi et al.
FRONTIERS IN PHARMACOLOGY (2019)
Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer
Yongmei Shen et al.
CELL COMMUNICATION AND SIGNALING (2019)
Update on ERbeta
Jan-Ake Gustafsson et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer
Kaori Yoriki et al.
SCIENTIFIC REPORTS (2019)
Estrogen receptors localization and signaling pathways in DU-145 human prostate cancer cells
Deborah S. Souza et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression
Helmut Bonkhoff
PROSTATE (2018)
Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard
Nicolas Mottet et al.
EUROPEAN UROLOGY (2018)
Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
Tetsuya Fujimura et al.
CANCERS (2018)
Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications
Erika Di Zazzo et al.
FRONTIERS IN ONCOLOGY (2018)
Advancing therapies in metastatic castration-resistant prostate cancer
Giulia Baciarello et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Consensus on molecular imaging and theranostics in prostate cancer
Stefano Fanti et al.
LANCET ONCOLOGY (2018)
Biochemical and Pathophysiological Premises to Positron Emission Tomography With Choline Radiotracers
Vincenzo Cuccurullo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity
Adam W. Nelson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression
Bilal Bin Hafeez et al.
MOLECULAR CANCER THERAPEUTICS (2017)
The EMT spectrum and therapeutic opportunities
Dominic C. Voon et al.
MOLECULAR ONCOLOGY (2017)
PET/CT with 18F-choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients
Ferdinando Calabria et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells
C. Pistore et al.
ONCOGENE (2017)
Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells
Xiaoyu Shi et al.
PROSTATE (2017)
Estrocen Receptor β as a Pharmaceutical Target
Margaret Warner et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Insufficient antibody validation challenges oestrogen receptor beta research
Sandra Andersson et al.
NATURE COMMUNICATIONS (2017)
Epithelial-mesenchymal transition in prostate cancer: an overview
Micaela Montanari et al.
ONCOTARGET (2017)
Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer
Dorota Jedroszka et al.
PLOS ONE (2017)
Prostate cancer stem cells: the role of androgen and estrogen receptors
Erika Di Zazzo et al.
ONCOTARGET (2016)
The emerging roles of orphan nuclear receptors in prostate cancer
Dinglan Wu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
AR aberrations and resistance to abiraterone or enzalutamide
Gerhardt Attard et al.
NATURE REVIEWS UROLOGY (2016)
Expression and regulation of the estrogen receptors in PC-3 human prostate cancer cells
R. Pisolato et al.
STEROIDS (2016)
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer
Michalis V. Karamouzis et al.
TRENDS IN CANCER (2016)
Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial
Tetsuya Fujimura et al.
BMC CANCER (2015)
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells
Dougba Noel Dago et al.
BMC GENOMICS (2015)
Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis
Marcus Ruscetti et al.
CANCER RESEARCH (2015)
Regulation of tumor cell plasticity by the androgen receptor in prostate cancer
Jennifer L. Bishop et al.
ENDOCRINE-RELATED CANCER (2015)
Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer
Prasenjit Dey et al.
PLOS ONE (2015)
Estrogen Induces Androgen-Repressed SOX4 Expression to Promote Progression of Prostate Cancer Cells
Muyi Yang et al.
PROSTATE (2015)
Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancer
Sweta Mishra et al.
ONCOTARGET (2015)
Estrogen receptor beta in prostate cancer: friend or foe?
Adam W. Nelson et al.
ENDOCRINE-RELATED CANCER (2014)
Effects of estrogen-related receptor alpha (ERRα) on proliferation and metastasis of human lung cancer A549 cells
Jian-wei Huang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2014)
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
Mercedes Marin-Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The Role of Estrogen Receptor β in Prostate Cancer
Paraskevi Christoforou et al.
MOLECULAR MEDICINE (2014)
NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer
Angela N. Flores et al.
NATURE REVIEWS UROLOGY (2014)
Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells
Margherita Piccolella et al.
PHARMACOLOGICAL RESEARCH (2014)
Epithelial-to-Mesenchymal Transition and Estrogen Receptor α Mediated Epithelial Dedifferentiation Mark the Development of Benign Prostatic Hyperplasia
Rui Shao et al.
PROSTATE (2014)
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
Dimple Chakravarty et al.
NATURE COMMUNICATIONS (2014)
Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease
Tobias Zellweger et al.
ENDOCRINE-RELATED CANCER (2013)
Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Matthew R. Smith et al.
JOURNAL OF UROLOGY (2013)
Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
Zeynep Madak-Erdogan et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Estrogen receptor β sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription
Paul Mak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
Alvaro Aytes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro
L. Wang et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2013)
Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment
Melanie J. Grubisha et al.
STEROIDS (2013)
Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review
Frank Kunath et al.
BMC MEDICINE (2012)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
David J. Mulholland et al.
CANCER RESEARCH (2012)
Aggressive Prostate Cancer Is Prevented in ERαKO Mice and Stimulated in ERβKO TRAMP Mice
Anna Slusarz et al.
ENDOCRINOLOGY (2012)
Estrogen Receptors β1 and β2 Have Opposing Roles in Regulating Proliferation and Bone Metastasis Genes in the Prostate Cancer Cell Line PC3
Prasenjit Dey et al.
MOLECULAR ENDOCRINOLOGY (2012)
Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
Jones T. Nauseef et al.
NATURE REVIEWS UROLOGY (2011)
ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
Paul Mak et al.
CANCER CELL (2010)
Reciprocal Activation of Prostate Cancer Cells and Cancer-Associated Fibroblasts Stimulates Epithelial-Mesenchymal Transition and Cancer Stemness
Elisa Giannoni et al.
CANCER RESEARCH (2010)
Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion
Yuet-Kin Leung et al.
ENDOCRINE-RELATED CANCER (2010)
Estrogen receptor beta and the progression of prostate cancer: role of 5 alpha-androstane-3 beta,17 beta-diol
Donatella Dondi et al.
ENDOCRINE-RELATED CANCER (2010)
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
Hiroshi Tanaka et al.
NATURE MEDICINE (2010)
Role of Cyclic AMP Response Element-Binding Protein in Insulin-like Growth Factor-I Receptor Up-regulation by Sex Steroids in Prostate Cancer Cells
Marco Genua et al.
CANCER RESEARCH (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Expression of RIZ1 Protein (Retinoblastoma-Interacting Zinc-Finger Protein 1) in Prostate Cancer Epithelial Cells Changes With Cancer Grade Progression and Is Modulated In Vitro by DHT and E2
Valentina Rossi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer
Simona Nanni et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
EMT: When epithelial cells decide to become mesenchymal-like cells
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2009)
A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia
Paloma Alonso-Magdalena et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis
Jing Yang et al.
DEVELOPMENTAL CELL (2008)
The role of estrogens and estrogen receptors in normal prostate growth and disease
Gail S. Prins et al.
STEROIDS (2008)
A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer
Karsten Gravdal et al.
CLINICAL CANCER RESEARCH (2007)
The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-α
Archana Dhasarathy et al.
MOLECULAR ENDOCRINOLOGY (2007)
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2
Xiaobo Wang et al.
NATURE CELL BIOLOGY (2007)
N-cadherin as a therapeutic target in cancer
Agnese Mariotti et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Src-dependent signalling pathway regulation by sex-steroid hormones: Therapeutic implications
Antimo Migliaccio et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity
Karin Jennbacken et al.
PROSTATE (2006)
Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: Results of a double-blind, placebo controlled, phase IIB clinical trial
David Price et al.
JOURNAL OF UROLOGY (2006)
Estrogen receptor (ER)-β isoforms:: A key to understanding ER-β signaling
Yuet-Kin Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Steroid receptor regulation of epidermal growth factor signaling through src in breast and prostate cancer cells: Steroid antagonist action
A Migliaccio et al.
CANCER RESEARCH (2005)
The androgen derivative 5α-androstane-3β,17β-diol inhibits prostate cancer cell migration through activation of the estrogen receptor β subtype
V Guerini et al.
CANCER RESEARCH (2005)
Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole
D Saltzstein et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2005)
Estrogens and anti-estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates
SM Ho
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Dynamic regulation of estrogen receptor-β expression by DNA methylation during prostate cancer development and metastasis
XG Zhu et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Putative functional characteristics of human estrogen receptor-beta isoforms
B Peng et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2003)
Differential expression of the estrogen receptor beta (ERβ) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma
T Fixemer et al.
PROSTATE (2003)
Epithelial-mesenchymal transitions in development and pathologies
JP Thiery
CURRENT OPINION IN CELL BIOLOGY (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
G Castoria et al.
EMBO JOURNAL (2001)
Comparative studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma
I Leav et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Phase II trial of toremifene in androgen-independent prostate cancer - A Penn cancer clinical trials group trial
S Stein et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2001)
Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation
A Migliaccio et al.
EMBO JOURNAL (2000)
Share Paper
